Page 230

options for the integration of community health workers in primary 1 care to address the health-related social needs of families, 2 including approaches to incorporate federal funding. 3 (45) $1,635,000 of the general fund—state appropriation for 4 fiscal year 2024, $1,024,000 of the general fund—state appropriation 5 for fiscal year 2025, and $1,765,000 of the general fund—federal 6 appropriation are provided solely for a technology solution for an 7 authoritative client identifier, or master person index, for state 8 programs within the health and human services coalition to uniformly 9 identify clients across multiple service delivery systems. The 10 coalition will clearly identify all state programs impacted by and 11 all fund sources used in development and implementation of this 12 project. This subsection is subject to the conditions, limitations, 13 and review requirements of section 701 of this act. 14 (46)(a) Sufficient amounts are appropriated in this section for 15 the authority to provide coverage for all federal food and drug 16 administration-approved HIV antiviral drugs without prior 17 authorization. This coverage must be provided to apple health clients 18 enrolled in both fee-for-service and managed care programs. 19 (b) Beginning July 1, 2023, upon initiation or renewal of a 20 contract with the authority to administer a medicaid managed care 21 plan, a managed care health care system shall provide coverage 22 without prior authorization for all federal food and drug 23 administration-approved HIV antiviral drugs. 24 (c) By December 1, 2023, and December 1, 2024, the authority must 25 submit to the fiscal committees of the legislature the projected and 26 actual expenditures and percentage of medicaid clients who switch to 27 a new drug class without prior authorization as described in (a) and 28 (b) of this subsection. 29 (47) The authority shall consider evidence-based recommendations 30 from the Oregon health evidence review commission when making 31 coverage decisions for the treatment of pediatric autoimmune 32 neuropsychiatric disorders associated with streptococcal infections 33 and pediatric acute-onset neuropsychiatric syndrome. 34 (48) $2,120,000 of the general fund—state appropriation for 35 fiscal year 2024, $2,120,000 of the general fund—state appropriation 36 for fiscal year 2025, and $9,012,000 of the general fund—federal 37 appropriation are provided solely to increase advanced life support 38 code A0426 by 64 percent, basic life support base rates for 39 p. 229 ESSB 5187.SL